Panagora Asset Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Panagora Asset Management’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-26,725	Closed	-$359K	–	1533
2023 Q1	$359K	Buy	+26,725	New	+$462K	﹤0.01%	1217
2021 Q3	–	Sell	-8,482	Closed	-$169K	–	2506
2021 Q2	$169K	Buy	8,482 +8,161	+2,542%	+$162K	﹤0.01%	1707
2021 Q1	$7K	Buy	+321	New	+$8.95K	﹤0.01%	2515
2018 Q1	–	Sell	-2,427	Closed	-$142K	–	2419
2017 Q4	$142K	Buy	+2,427	New	+$153K	﹤0.01%	1780
2016 Q3	–	Sell	-4,001	Closed	-$571K	–	2476
2016 Q2	$571K	Buy	+4,001	New	+$583K	﹤0.01%	1328
2015 Q3	–	Sell	-254	Closed	-$61K	–	2453
2015 Q2	$61K	Sell	254 -173	-41%	-$46.1K	﹤0.01%	2095
2015 Q1	$120K	Buy	+427	New	+$92.5K	﹤0.01%	1887
2014 Q3	–	Sell	-278	Closed	-$66K	–	2378
2014 Q2	$66K	Buy	278 +149	+116%	+$39.3K	﹤0.01%	2030
2014 Q1	$43K	Sell	129 -49,755	-100%	-$16.8M	﹤0.01%	2124
2013 Q4	$3.41M	Buy	49,884 +48,605	+3,800%	+$2.81M	0.02%	655
2013 Q3	$88K	Hold	1,279	–	–	﹤0.01%	1896
2013 Q2	$57K	Buy	+1,279	New	+$43.7K	﹤0.01%	1993

Other funds holding ICPT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

DCM

DG Capital Management New York $326M AUM 39.67% 1-Year Est. Return

Panagora Asset Management's ICPT Position: Q2 2023 in Review

Panagora Asset Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q2 2023, closing a stake of 26,725 shares — an estimated $359K sold.

Panagora Asset Management first reported a position in ICPT in Q2 2013 and held it in 12 quarters. The position peaked at $3.41M in Q4 2013. 126 funds tracked by Wall St. Rank hold ICPT as of Q2 2023.

Panagora Asset Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q2 2023 after selling out during the quarter.
Panagora Asset Management sold 26,725 Intercept Pharmaceuticals, Inc. shares in Q2 2023, an estimated $359K.
Panagora Asset Management first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2013 and held it in 12 quarters.
Panagora Asset Management's Intercept Pharmaceuticals, Inc. position peaked at $3.41M in Q4 2013.
126 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q2 2023.

Based on Panagora Asset Management's 13F filing for Q2 2023, filed 11 Aug 2023.